IL1B and obesity disorder: Reduced levels of IL-1β in our population may be explained by results from HFD-induced obesity rat models that underwent RYGB and showed that lower levels on the aforementioned cytokine resulted from diminished inflammasome activation in visceral adipose tissue (VAT)52.